At Anuli Med Spa, our semaglutide program goes far beyond the injection itself
Kowalska K, Habrowska-Grczyska DE, Piastowska-Ciesielska AW
According to the company, omitting this information may give healthcare professionals and patients an incomplete understanding of the available scientific evidence
Because millions of people are already taking GLP-1s for health conditions like diabetes, obesity, and cardiovascular disease, with more indications in progress, there are millions of people who will reduce their substance use simply as an unexpected, and maybe even unnoticed, side effect of the medications, as well as millions more who will avoid developing addictions or unhealthy substance use patterns in the first place
Other explanations point to weight loss itself
The effects of sequence variation on genome-wide NRF2 binding-new target genes and regulatory SNPs